Gaomi Jindeyuan Shoes Material Co., Ltd. – Trademark Portfolio
Entity Type: 03
Gaomi Jindeyuan Shoes Material Co., Ltd. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 25 (Clothing) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CLITENK. The owner is based in Gaomi, Shandong Provin.
West Liquan Street, Weifan District
Gaomi, Shandong Provin 261500 , CN
Showing of trademarks Trademarks
Trademark Classifications
Gaomi Jindeyuan Shoes Material Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Gaomi Jindeyuan Shoes Material Co., Ltd. have?
Gaomi Jindeyuan Shoes Material Co., Ltd. has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned.
What trademark classes does Gaomi Jindeyuan Shoes Material Co., Ltd. file in?
Gaomi Jindeyuan Shoes Material Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 25 (Clothing). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Gaomi Jindeyuan Shoes Material Co., Ltd.'s most well-known trademarks?
Gaomi Jindeyuan Shoes Material Co., Ltd.'s registered trademark portfolio includes well-known marks such as CLITENK. These are among 4 currently registered trademarks in the portfolio.
What is Gaomi Jindeyuan Shoes Material Co., Ltd.'s trademark registration success rate?
Gaomi Jindeyuan Shoes Material Co., Ltd. has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.